OPEN END TURBO LONG - ABBOTT LABORATORIES Stock

Certificat

DE000MC7UU09

Market Closed - Börse Stuttgart 15:54:40 2024-05-31 EDT
1.67 EUR +0.60% Intraday chart for OPEN END TURBO LONG - ABBOTT LABORATORIES
1 month-22.33%
3 months-51.03%
Date Price Change
24-05-31 1.67 +0.60%
24-05-30 1.66 +3.75%
24-05-29 1.6 -3.03%
24-05-28 1.65 -10.33%
24-05-27 1.84 -1.08%

Delayed Quote Börse Stuttgart

Last update May 31, 2024 at 03:54 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ABBOTT LABORATORIES
Issuer Morgan Stanley
WKN MC7UU0
ISINDE000MC7UU09
Date issued 2020-04-01
Strike 83.88 $
Maturity Unlimited
Parity 10 : 1
Emission price 1.01
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.05
Lowest since issue 0.69

Company Profile

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).
Sector
-
More about the company

Ratings for Abbott Laboratories

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Abbott Laboratories

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
102.2 USD
Average target price
125.4 USD
Spread / Average Target
+22.69%
Consensus